Severity: Warning
Message: file_get_contents(https://...@pubfacts.com&api_key=b8daa3ad693db53b1410957c26c9a51b4908&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
Filename: helpers/my_audit_helper.php
Line Number: 176
Backtrace:
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 176
Function: file_get_contents
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 250
Function: simplexml_load_file_from_url
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3122
Function: getPubMedXML
File: /var/www/html/application/controllers/Detail.php
Line: 575
Function: pubMedSearch_Global
File: /var/www/html/application/controllers/Detail.php
Line: 489
Function: pubMedGetRelatedKeyword
File: /var/www/html/index.php
Line: 316
Function: require_once
In recent years, polypeptides have been standing out as excellent candidates to replace polyethylene glycol (PEG) with adequate biocompatibility and biodegradability. In this study, we found that (VELPPP), an anionic γ-zein-based proline-rich peptide with a polyproline-II helical structure, was able to impart liposomes with considerable stability and significantly prolonged blood circulation in vivo. Furthermore, we have shown that (VELPPP)-modified liposomes induced negligible anti-peptide IgM production, and no noticeable accelerated blood clearance after repeated or multi-dose administration. The biodistribution study suggested that compared to PEGylated liposomes, (VELPPP)-modified liposomes showed a slight inclination of accumulation in livers, and a decreased entrapment in most of the other organs over long hours. In conclusion, (VELPPP) has shown considerable capacity in establishing stealth nanocarriers, providing inspiring insights into developing alternatives for PEGylation.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jconrel.2024.12.029 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!